Opus Genetics, Inc.
US ˙ NasdaqCM ˙ US67577R1023

SecurityIRD / Opus Genetics, Inc.
InstitutionCitadel Advisors Llc
ManagerKen Griffin
Latest Disclosed Ownership120,900 shares
Latest Disclosed Value $ 550,095
Citadel Advisors Llc ownership in IRD / Opus Genetics, Inc.

On May 15, 2026 - Citadel Advisors Llc filed a 13F-HR form disclosing ownership of 120,900 shares of Opus Genetics, Inc. (US:IRD) valued at $550,095 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 180,721 shares of Opus Genetics, Inc.. This represents a change in shares of -33.10% during the quarter. The current value of the position is $487,227 USD.

Citadel Advisors Llc has a history of taking positions in derivatives of the underlying security (IRD) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

IRD / Opus Genetics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F OPUS GENETICS COM 67577R102 120,900 -59,821 -33.10 550 51.52 0.0001
2026-02-17 2025-12-31 13F OPUS GENETICS COM 67577R102 180,721 67,305 59.34 363 94.12 0.0001
2025-11-14 2025-09-30 13F OPUS GENETICS COM 67577R102 113,416 113,416 187 0.0000
2025-08-14 2025-06-30 13F OPUS GENETICS COM 67577R102 0 -67,877 -100.00 0 -100.00
2025-05-15 2025-03-31 13F OPUS GENETICS COM 67577R102 67,877 -107,896 -61.38 67 -68.42 0.0000
2025-02-14 2024-12-31 13F OPUS GENETICS COM 67577R102 175,773 88,954 102.46 209 84.96 0.0000
2024-11-14 2024-09-30 13F OCUPHIRE PHARMA COM 67577R102 86,819 72,721 515.82 114 438.10 0.0000
2024-08-14 2024-06-30 13F OCUPHIRE PHARMA COM 67577R102 14,098 -65,432 -82.27 22 -86.79 0.0000
2024-05-15 2024-03-31 13F OCUPHIRE PHARMA COM 67577R102 79,530 64,255 420.65 160 253.33 0.0000
2024-02-14 2023-12-31 13F OCUPHIRE PHARMA COM 67577R102 15,275 15,275 46 0.0000
2023-08-14 2023-06-30 13F OCUPHIRE PHARMA COM 67577R102 0 -3,946 -100.00 0 -100.00
2023-05-15 2023-03-31 13F OCUPHIRE PHARMA COM 67577R102 3,946 -34,066 -89.62 15 -89.55 0.0000
2023-02-14 2022-12-31 13F OCUPHIRE PHARMA COM 67577R102 38,012 38,012 134 0.0000
2022-11-14 2022-09-30 13F OCUPHIRE PHARMA COM 67577R102 0 -16,458 -100.00 0 -100.00
2022-08-15 2022-06-30 13F OCUPHIRE PHARMA COM 67577R102 16,458 16,458 32 0.0000
2022-02-14 2021-12-31 13F OCUPHIRE PHARMA Cmn 67577R102 0 -57,502 -100.00 0 -100.00
2021-11-15 2021-09-30 13F OCUPHIRE PHARMA Cmn 67577R102 57,502 43,245 303.32 296 294.67 0.0001
2021-08-16 2021-06-30 13F OCUPHIRE PHARMA COM 67577R102 14,257 14,257 75 0.0000
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-11-14 2025-09-30 13F OPUS GENETICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-08-14 2025-06-30 13F OPUS GENETICS COM Call 19,000 38.69 18 30.77 n/a n/a n/a
2025-05-15 2025-03-31 13F OPUS GENETICS COM Call 13,700 8.73 13 -7.14 n/a n/a n/a
2025-02-14 2024-12-31 13F OPUS GENETICS COM Call 12,600 -10.64 15 -22.22 n/a n/a n/a
2024-11-14 2024-09-30 13F OCUPHIRE PHARMA COM Call 14,100 605.00 18 500.00 n/a n/a n/a
2024-08-14 2024-06-30 13F OCUPHIRE PHARMA COM Call 2,000 -44.44 3 -57.14 n/a n/a n/a
2024-05-15 2024-03-31 13F OCUPHIRE PHARMA COM Call 3,600 -67.86 7 -78.79 n/a n/a n/a
2024-02-14 2023-12-31 13F OCUPHIRE PHARMA COM Call 11,200 -75.60 34 -78.43 n/a n/a n/a
2023-11-14 2023-09-30 13F OCUPHIRE PHARMA COM Call 45,900 171.60 154 109.59 n/a n/a n/a
2023-08-14 2023-06-30 13F OCUPHIRE PHARMA COM Call 16,900 30.00 73 52.08 n/a n/a n/a
2023-05-15 2023-03-31 13F OCUPHIRE PHARMA COM Call 13,000 420.00 49 500.00 n/a n/a n/a
2023-02-14 2022-12-31 13F OCUPHIRE PHARMA COM Call 2,500 -90.00 9 -84.00 n/a n/a n/a
2022-11-14 2022-09-30 13F OCUPHIRE PHARMA COM Call 25,000 -9.42 50 -5.66 n/a n/a n/a
2022-08-15 2022-06-30 13F OCUPHIRE PHARMA COM Call 27,600 -16.36 53 -50.47 n/a n/a n/a
2022-05-16 2022-03-31 13F OCUPHIRE PHARMA COM Call 33,000 57.14 107 37.18 n/a n/a n/a
2022-02-14 2021-12-31 13F OCUPHIRE PHARMA COM Call 21,000 -35.38 78 -53.29 n/a n/a n/a
2021-11-15 2021-09-30 13F OCUPHIRE PHARMA Cmn Call 32,500 167 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-08-14 2025-06-30 13F OPUS GENETICS COM Put 0 -100.00 0 n/a n/a n/a
2025-05-15 2025-03-31 13F OPUS GENETICS COM Put 1,000 -44.44 1 -100.00 n/a n/a n/a
2025-02-14 2024-12-31 13F OPUS GENETICS COM Put 1,800 125.00 2 100.00 n/a n/a n/a
2024-11-14 2024-09-30 13F OCUPHIRE PHARMA COM Put 800 -60.00 1 -66.67 n/a n/a n/a
2024-08-14 2024-06-30 13F OCUPHIRE PHARMA COM Put 2,000 -67.74 3 -75.00 n/a n/a n/a
2024-05-15 2024-03-31 13F OCUPHIRE PHARMA COM Put 6,200 210.00 12 100.00 n/a n/a n/a
2024-02-14 2023-12-31 13F OCUPHIRE PHARMA COM Put 2,000 -81.65 6 -83.33 n/a n/a n/a
2023-11-14 2023-09-30 13F OCUPHIRE PHARMA COM Put 10,900 32.93 37 2.86 n/a n/a n/a
2023-08-14 2023-06-30 13F OCUPHIRE PHARMA COM Put 8,200 412.50 36 483.33 n/a n/a n/a
2023-05-15 2023-03-31 13F OCUPHIRE PHARMA COM Put 1,600 -79.49 6 -77.78 n/a n/a n/a
2023-02-14 2022-12-31 13F OCUPHIRE PHARMA COM Put 7,800 28 n/a n/a n/a
2022-05-16 2022-03-31 13F OCUPHIRE PHARMA COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-02-14 2021-12-31 13F OCUPHIRE PHARMA COM Put 29,800 -11.57 111 -36.21 n/a n/a n/a
2021-11-15 2021-09-30 13F OCUPHIRE PHARMA Cmn Put 33,700 174 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.